Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 497-502, March 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sidwell, R. W.
Right arrow Articles by Schabel, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sidwell, R. W.
Right arrow Articles by Schabel, F. M., Jr.

The Effect of Treatment with a Combination of 6-Mercaptopurine and Porfiromycin on an Established Friend Leukemia Virus Infection1

Robert W. Sidwell, Glen J. Dixon, Patricia Compton and Frank M. Schabel, Jr.

Virus Section, Chemotherapy Research Department, Southern Research Institute, Birmingham, Alabama 35205

The effect of parenteral therapy with combinations of 6-mercaptopurine and porfiromycin on established infections of Friend leukemia virus in Swiss mice was studied. In one experiment both drugs were markedly effective in reducing virusinduced splenomegaly and virus titers in the plasma and spleens, but treatment with the combination of drugs was more effective than treatment with either drug used alone, when comparative nonlethal drug levels were used. In a second experiment these results were confirmed, and reduction in blood hematocrit values and in hepatomegaly were used successfully as additional criteria for evaluation. In all experiments treatment was not initiated until 14 days after virus inoculation when the virus infection was established in the animals as shown by demonstrable splenomegaly and spleen and plasma virus titers.

1 Supported by Contract PH-43-63-68 from the Cancer Chemotherapy National Service Center, National Cancer Institute, USPHS.

Received 7/25/68. Accepted 11/ 7/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.